BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38665909)

  • 1. Evaluation of cytokine profiles related to
    Yasuda I; Saludar NRD; Sayo AR; Suzuki S; Yokoyama A; Ozeki Y; Kobayashi H; Nishiyama A; Matsumoto S; Cox SE; Tanaka T; Yamashita Y
    Front Immunol; 2024; 15():1330796. PubMed ID: 38665909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PpiA antigen specific immune response is a potential biomarker for latent tuberculosis infection.
    Pathakumari B; Anbarasu D; Parthasarathy RT; Raja A
    Tuberculosis (Edinb); 2015 Dec; 95(6):736-743. PubMed ID: 26546406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro- and anti-inflammatory cytokines against Rv2031 are elevated during latent tuberculosis: a study in cohorts of tuberculosis patients, household contacts and community controls in an endemic setting.
    Belay M; Legesse M; Mihret A; Bekele Y; Ottenhoff TH; Franken KL; Bjune G; Abebe F
    PLoS One; 2015; 10(4):e0124134. PubMed ID: 25897840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
    Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
    Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rv2204c, Rv0753c and Rv0009 antigens specific T cell responses in latent and active TB - a flow cytometry-based analysis.
    Pathakumari B; Devasundaram S; Maddineni P; Raja A
    Int J Med Microbiol; 2018 Mar; 308(2):297-305. PubMed ID: 29325881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-Mediated Immune Responses to
    Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
    Front Immunol; 2020; 11():103. PubMed ID: 32117257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker.
    Borgström E; Andersen P; Atterfelt F; Julander I; Källenius G; Maeurer M; Rosenkrands I; Widfeldt M; Bruchfeld J; Gaines H
    PLoS One; 2012; 7(11):e43438. PubMed ID: 23144772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens.
    Kellar KL; Gehrke J; Weis SE; Mahmutovic-Mayhew A; Davila B; Zajdowicz MJ; Scarborough R; LoBue PA; Lardizabal AA; Daley CL; Reves RR; Bernardo J; Campbell BH; Whitworth WC; Mazurek GH
    PLoS One; 2011; 6(11):e26545. PubMed ID: 22132075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of a cytokine and IFN-γ-induced chemokine mRNA assay after Mycobacterium tuberculosis-specific antigen stimulation in whole blood from infected individuals.
    Kim S; Lee H; Kim H; Kim Y; Cho JE; Jin H; Kim DY; Ha SJ; Kang YA; Cho SN; Lee H
    J Mol Diagn; 2015 Jan; 17(1):90-9. PubMed ID: 25528189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
    Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
    BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of ESAT-6/CFP-10-induced IFN-γ, TNF-α and IL-10 with clinical tuberculosis: evidence from cohorts of pulmonary tuberculosis patients, household contacts and community controls in an endemic setting.
    Abebe F; Belay M; Legesse M; Mihret A; Franken KS
    Clin Exp Immunol; 2017 Aug; 189(2):241-249. PubMed ID: 28374535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy.
    Mattos AM; Almeida Cde S; Franken KL; Alves CC; Abramo C; de Souza MA; L'Hotellier M; Alves MJ; Ferreira AP; Oliveira SC; Ottenhoff TH; Teixeira HC
    Int Immunol; 2010 Sep; 22(9):775-82. PubMed ID: 20624776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of phenotype and absolute number of circulating heparin-binding hemagglutinin, ESAT-6 and CFP-10, and purified protein derivative antigen-specific CD4 T cells can discriminate active from latent tuberculosis infection.
    Hutchinson P; Barkham TM; Tang W; Kemeny DM; Chee CB; Wang YT
    Clin Vaccine Immunol; 2015 Feb; 22(2):200-12. PubMed ID: 25520147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4
    Yamashita Y; Oe T; Kawakami K; Osada-Oka M; Ozeki Y; Terahara K; Yasuda I; Edwards T; Tanaka T; Tsunetsugu-Yokota Y; Matsumoto S; Ariyoshi K
    Front Immunol; 2019; 10():2807. PubMed ID: 31849981
    [No Abstract]   [Full Text] [Related]  

  • 15. Ethnicity-tailored novel set of ESAT-6 peptides for differentiating active and latent tuberculosis.
    Singh SB; Biswas D; Rawat J; Sindhwani G; Patras A; Devrani S; Sarkar P; Mitra S; Gupta SK
    Tuberculosis (Edinb); 2013 Nov; 93(6):618-24. PubMed ID: 24011630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell response to alpha crystallin and Mycobacterium tuberculosis specific antigens using ex-vivo elispot assay for detecting latent tuberculosis infection in Addis Ababa, Ethiopia.
    Mamo G; Mihret A; Taffesse M; Gebru G; Afework M; Yamuah LK; Wassie L; Abebe M; Aseffa A; Parida SK
    Ethiop Med J; 2014 Jan; Suppl 1():15-22. PubMed ID: 24696984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum antibody profiles in individuals with latent Mycobacterium tuberculosis infection.
    Maekura R; Kitada S; Osada-Oka M; Tateishi Y; Ozeki Y; Fujicawa T; Miki M; Jyunnko O; Mori M; Matsumoto S
    Microbiol Immunol; 2019 Mar; 63(3-4):130-138. PubMed ID: 30851131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
    Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
    Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cells co-producing Mycobacterium tuberculosis-specific type 1 cytokines for the diagnosis of latent tuberculosis.
    Nemeth J; Winkler HM; Karlhofer F; Selenko-Gebauer N; Graninger W; Winkler S
    Eur Cytokine Netw; 2010 Mar; 21(1):34-9. PubMed ID: 20146988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.